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ABSTRACT
Objectives: To apply sociological theories to
understand public trust in extended services provided
by community pharmacists relative to those provided
by general practitioners (GPs).
Design: Qualitative study involving focus groups with
members of the public.
Setting: The West of Scotland.
Participants: 26 purposively sampled members of the
public were involved in one of ﬁve focus groups. The
groups were composed to represent known groups of
users and non-users of community pharmacy, namely
mothers with young children, seniors and men.
Results: Trust was seen as being crucial in healthcare
settings. Focus group discussions revealed that
participants were inclined to draw unfavourable
comparisons between pharmacists and GPs.
Importantly, participants’ trust in GPs was greater than
that in pharmacists. Participants considered
pharmacists to be primarily involved in medicine
supply, and awareness of the pharmacist’s extended
role was low. Participants were often reluctant to trust
pharmacists to deliver unfamiliar services, particularly
those perceived to be ‘high risk’. Numerous system-
based factors were identiﬁed, which reinforce patient
trust and conﬁdence in GPs, including GP registration
and appointment systems, GPs’ expert/gatekeeper role
and practice environments. Our data indicate that the
nature and context of public interactions with GPs
fostered familiarity with a speciﬁc GP or practice,
which allowed interpersonal trust to develop. By
contrast, participants’ exposure to community
pharmacists was limited. Additionally, a good
understanding of the GPs’ level of training and role
promoted conﬁdence.
Conclusion: Current UK initiatives, which aim to
implement a range of pharmacist-led services, are
undermined by lack of public trust. It seems
improbable that the public will trust pharmacists to
deliver unfamiliar services, which are perceived to be
‘high risk’, unless health systems change in a way that
promotes trust in pharmacists. This may be achieved
by increasing the quality and quantity of patient
interactions with pharmacists and gaining GP support
for extended pharmacy services.
INTRODUCTION
The global undersupply of trained health-
care professionals has resulted in initiatives
to expand the roles of allied health profes-
sionals to complete tasks, which were previ-
ously the preserve of general practitioners
(GPs).
1 2 International models of pharmacy
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ARTICLE SUMMARY
Article focus
- Why do the public access GPs for services, which
are also available in community pharmacies?
- What sort of services do the public trust
community pharmacists to deliver?
- What factors underpin greater public trust in GP
services relative to community pharmacy
services?
Key messages
- Public trust in GPs was greater than that in
pharmacists; many were reluctant to trust
pharmacists to deliver unfamiliar ‘high-risk’
services.
- Numerous system-based factors reinforce public
trust and conﬁdence in GPs, including GP
registration and appointment systems, GPs’
expert/gatekeeper role and practice environ-
ments.
- This study suggests that increasing the quality
and quantity of patient interactions with phar-
macists and gaining GP support for extended
pharmacy services could build public trust.
Strengths and limitations of this study
- This is the ﬁrst study to apply sociological
perspectives of trust to understand public
perspectives of community pharmacy.
- The qualitative approach has allowed us to gather
in-depth information in an under-researched
area.
- The study methodology limits generalisation,
although theme saturation was achieved and
the context of the study is explicitly deﬁned.
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Open Access Researchfunding, regulation and service provision vary; however,
there are certain commonalities.
3 In most countries,
community pharmacists have traditionally been involved
in medicine supply. The UK policy and pharmacists’
professional organisations have emphasised the poten-
tial of community pharmacists to extend their roles.
4e8
Extended pharmacy services include preventive roles
aimed at improving public health and reducing health
inequalities, managing long-term conditions and medi-
cine reviews.
91 0However, international uptake of such
extended services has been disappointing.
11e14 Box 1
provides information on NHS GP and pharmacy services
in Scotland. The general public are known to defer to
GPs for many services, which are also available in
community pharmacies.
15 Previous studies have
explored barriers to pharmacists’ role expansion from
the perspective of GPs, pharmacists, service users, but
the general public’s views have seldom been
canvased.
16e19
Trust in healthcare
This is the ﬁrst known study to apply sociological theo-
ries to understand public trust in services provided by
community pharmacists relative to those provided by
GPs. This is important because trust is central to medical
relationships and is essential to effective therapeutic
encounters.
20 Trust underpins patients’ willingness to
seek care, reveal information, follow treatment plans and
recommend a service.
20 Trust can, therefore, be seen to
mediate health outcomes and is critical to the produc-
tion of health. It is important to understand the sources
of (mis)trust in health services, in particular, to inform
the development of trustworthy services.
Trust is a complex phenomenon and is a concept that
has yet to be universally deﬁned within and across
disciplines.
21e25 However, health sociology literature
does provide some consistency. Trust may be deﬁned as
the ‘optimistic acceptance of a vulnerable situation
which is based on positive expectations of the intentions
of the trusted individual or institution’.
20 22 26 In the case
of healthcare, vulnerability arises because health service
users are ill and require care in an environment of
specialist knowledge that creates asymmetries, estab-
lishing agency relationships between users and
providers.
20 Interpersonal trust is an emotional assess-
ment of motivations and intentions of the provider not
just the results.
20 In the case of healthcare, trust
in individuals and in the system are important. Trust in
health provision relies on a combination of trust in
individuals and systems.
27
Trust, familiarity, conﬁdence and risk
It is beyond the scope of this paper to provide an
exhaustive analysis of the theoretical literature on trust;
rather, we will focus on relevant theoretical constructs
and their applicability to this healthcare setting. Trust
functions as a way to reduce complexity in society.
28
Placing trust in individuals and systems simpliﬁes our
decisions to act.
29 Risk is central to understanding the
phenomenon of trust.
30 Trust helps people to make
future decisions based on experience and also uses the
knowledge of the past to minimise risk.
29 Luhmann
29
discussed trust and familiarity as related concepts; both
reduce complexity in society on the basis of past expe-
rience. Trust develops with familiarity, and familiarity is
used as a mechanism to calculate risk.
28 Luhmann
argued that individuals base decisions to place (mis)trust
in an individual or system on both experience and risks
associated with decisions made for the future. In the
context of healthcare, individuals are likely to establish
trust with known health professionals, as their experi-
ence of that person increases. Trust is likely to be
enhanced in established systems known to an individual.
Conﬁdence is required in situations of unfamiliarity.
By conﬁdence, Luhmann meant having faith in an
individual or system, such as politics, banking, educa-
tion, transport, business and healthcare. When an indi-
vidual relies on conﬁdence, there is an expectation that
they will not be disappointed. When expectations are not
fulﬁlled, trust results in an internal attribution of blame,
whereas conﬁdence results in an external attribution of
blame. This is because an individual chooses to trust; by
Box 1 General practice and pharmacy services in
Scotland
- The NHS is a national system operating in the UK that is
ﬁnanced primarily by public taxation, and it is usually free
at the point of access.
- In Scotland, general practitioners (GPs) and community
pharmacies operate as independent contractors
providing a range of services within the NHS.
- Most people are registered with a GP and appointments
are not charged.
- GPs usually work in a clinic setting.
- In some cases, GPs charge for certain services or
products not funded by the NHS, for example, there may
be charges for some travel vaccinations.
- Pharmacists in Scotland provide dispensing services, as
well as a chronic medication service, minor ailment
services, public health services, acute medication
services, ﬂu vaccination supply and some locally
commissioned services (these include advice to residen-
tial homes, methadone supply, needle exchange and
domiciliary oxygen).
- The pharmacy services listed above are funded by the
NHS, and there is no charge to the patient. Prescription
charges were abolished in Scotland in 2011.
- Most people are not registered with a pharmacist, unless
a speciﬁc service has been used, which requires
registration, examples include the minor ailment service
or chronic medication service.
- A number of non-NHS services are available at speciﬁc
pharmacies at a charge, in Scotland, including weight
management and seasonal ﬂu vaccination.
- Community pharmacies in Scotland tend to be operated
by commercial operations in retail settings. Most
generate proﬁt from the sale of medicines, medical
equipment and other sundry items.
2 Gidman W, Ward P, McGregor L. BMJ Open 2012;2:e000939. doi:10.1136/bmjopen-2012-000939
Public trust in community pharmacy servicescontrast, conﬁdence is based on expectation and is not
a matter of choice.
Declining trust in healthcare
Research suggests that the move from what is termed
‘modern’ to ‘late/high modern’ society has been
accompanied by a declining level of public trust in
healthcare.
31 Lack of trust can be described as distrust or
mistrust. Distrust can be deﬁned as a healthy scepticism,
while mistrust comprises a more unhealthy cynicism
driven by actual or suspected misdeeds.
32 Public
concerns about healthcare stem from evidence of ineq-
uitable allocation of resources, as well as high-proﬁle
medical and safety scandals.
31 The overarching declining
trust in government and social administration is linked
by uncertainty in science, technology and expert
systems.
33 34 It is important to consider that despite
public mistrust of medical practitioners, the public
continues to access services.
31 Hall et al
20 suggested that
individuals have no choice but to trust the motives and
competence of medical professions since they do not
have the knowledge or skills to judge levels of expertise.
Additionally, GPs, in particular, act as gatekeepers to
resources as well as specialised services in secondary
care.
16 This results in hierarchical relationships between
healthcare providers and reinforces user dependence.
35
Greener
35 proposed that the increasing power base of
the medical professional results in coercive or depen-
dent trust relationships.
Interpersonal and institutional trust
Trust can be placed in individuals (interpersonal) trust
and/or the social systems they represent (institutional
trust). Institutional trust could include the medical
system (knowledge of medicines), the scientiﬁc system
(evidence-based practice), the economic system (the
retail or consumer setting), the legal system (their ability
to restrict access to certain medicines on legal grounds)
or the artistic system (the aesthetics of the stores). The
two types of trust are inter-related in that an individual
represents the health system and, therefore, might
inﬂuence trust in the system. It is entirely possible,
however, for an individual to trust an individual health
professional and distrust the underlying system. More-
over, individuals can mistrust an individual working in
a trustworthy system. Interpersonal relationships can
shape how people feel about health systems and trust in
the system can contribute to the development of inter-
personal trust,
36 although the way in which interpersonal
trust might affect institutional trust is much less clear.
37
The majority of the research conducted into trust in the
healthcare setting has focused on the interpersonal
aspects of trust. Evidence suggests that despite declining
trust in health systems, interpersonal trust in speciﬁc
health practitioners remains relatively high.
38 Few
studies have considered system-based trust issues.
This study aimed to use focus group methodology to
explore public perspectives and experiences of commu-
nity services following policy changes and role expan-
sion. This study aimed to understand the barriers to
pharmacist role expansion from the public’s perspective.
The approach to analysis was inductive with research
themes arising from the data. It became clear during
data gathering that trust was an important issue.
Consequently, this paper applies sociological perspec-
tives of trust to the qualitative data gathered from the
public in Scotland. This paper particularly focuses on
public trust in pharmacy services relative to GP services
and the system/institutional-based trust factors that
underpin relatively high levels of interpersonal trust in
GPs.
METHODOLOGY
This exploratory qualitative study used a focus group
design to elicit the views of the general public on expe-
riences and expectations of community pharmacy. A
topic guide was developed that would provoke opinions
and generate discussion (see appendix 1). All focus
groups were conducted between 5 and 24 March 2010.
University of Strathclyde Research Ethic Committee
approval was obtained.
Justiﬁcation for methodology selected
Focus group methodology was chosen to address the
study aims as it is reported to provide the richest data in
relation to public views of priorities in health services.
39
Furthermore, focus groups are useful for in-depth
exploration of health research topics and provide an
unobtrusive method for collecting data on public views
of health services, while providing more critical
comments than other more conventional data collection
techniques, such as individual one-to-one interviews.
39 40
Focus groups are regarded as an ideal method for
exploratory qualitative research due to their ability to
‘inductively generate research ideas’ and are useful for
exploring participants’ perceptions, actions and the
meaning assigned to them.
41
Participants
Data collection continued until theme saturation was
achieved. A total of 26 people participated in one of ﬁve
focus groups in the vicinity of Glasgow, Scotland.
Participants were recruited through non-pharmacy or
national health-related voluntary and charity organisa-
tions. Details of the focus groups are provided in tables 1
and 2. All participants were resident in Scotland and
were of British nationality, apart from those in group 3
(mothers with young children), who were from various
regions of Africa. This group was of interest because
immigrant populations might have different views of
community pharmacy services. Poor health outcomes in
immigrant populations have been linked to inequitable
access to health services, due to cultural differences and
low levels of health literacy.
42 43 The other groups were
composed to represent known groups of users and non-
users of community pharmacy, namely mothers with
young children, seniors and men. The most regular
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Public trust in community pharmacy servicespharmacy users are women of age 35e74 years and men
older than 55 years.
12 Men aged 16e24 years use phar-
macies the least.
12
Participants were compensated for their time (a £15
shopping voucher was distributed at the end of the focus
group discussions).
Focus groups
The same facilitator (Joseph Cowley) and observer (LM)
coordinated each focus group. The focus groups were
conducted in a place convenient and familiar to the
participants and lasted an average of 53 min. Informa-
tion sheets were provided to potential participants
during the recruitment stage, and demographic details
and consent were obtained prior to participation.
Speciﬁcally, participants signed consent forms indicating
that they understood study objectives, data collection
and analysis methods, as well as, consenting to audio
recording and data transcription. Each focus group was
recorded, transcribed, anonymised and analysed using
thematic analysis.
44
Analysis
Analysis was inductive with themes being derived from
the data. Two researchers (WG and LM) separately coded
the transcripts and discussed emerging themes.
45 46
Researchers read the transcripts and familiarised them-
selveswiththecontentpriortomanuallycodingthem.
29 30
Coded sections of transcripts were collated to develop
themes. Researchers indexed themes and grouped
quotations into thematic areas prior to identifying
subthemes. A third researcher (PW) independently veri-
ﬁed themes and data analysis. Themes were redeﬁned
where necessary to ensure coherence with coded text and
representation of the data set as a whole. Finally, themes
were considered in relation to one another and trust
theoretical frameworks. One of the criticisms levelled at
the reporting of ﬁndings from focus groups has been that
the interaction and discussion are often neglected.
39
Therefore,wehaveaimedtoretainsomeofthediscussion
in the use of our direct quotations. Discussions between
participants are given in italics.
RESULTS
Trust emerged as a core theme from the data, which
could be divided into two major subthemes. Speciﬁcally,
analysis considered data in the context of trust, famil-
iarity, conﬁdence and risk. Additionally, thematic anal-
ysis was used to identify system/institutional factors that
affected public trust.
Trust, familiarity, conﬁdence and risk
Focus group discussions were primarily intended to
centre on community pharmacy, although participants
drew comparison between pharmacists and GPs in all
groups (see box 2). From discussions, it seemed that
many used community pharmacy as a ﬁrst port of call for
convenience. However, by preference, the majority would
consult a GP for most primary healthcare needs. Partici-
pants commonly rationalised preferences by stating that
they were more familiar with the GP, and levels of
conﬁdence and trust in GPs were higher. Some
Table 1 Details of focus groups
Focus groups
Total 12345
Number of participants 6 7 4 4 5 26
Gender (M:F) 0:6 4:3 0:4 0:4 5:0 9:14
Age
Mean 73.67 62.57 27.00 29.75 47.40 51.69
SD 14.51 9.03 6.98 7.27 17.07 21.16
Range 58e94 52e77 18e35 23e40 21e63 18e94
Table 2 Details of focus group participants
Respondent Age Sex Group Group description
1 58 F 1 Seniors 1
2 76 F 1 Seniors 1
3 87 F 1 Seniors 1
4 62 F 1 Seniors 1
5 65 F 1 Seniors 1
6 94 F 1 Seniors 1
7 68 F 2 Seniors 2
8 65 M 2 Seniors 2
9 77 M 2 Seniors 2
10 66 F 2 Seniors 2
11 53 F 2 Seniors 2
12 52 M 2 Seniors 2
13 57 M 2 Seniors 2
14 28 F 3 Mothers 1
15 27 F 3 Mothers 1
16 35 F 3 Mothers 1
17 18 F 3 Mothers 1
18 27 F 4 Mothers 2
19 29 F 4 Mothers 2
20 40 F 4 Mothers 2
21 23 F 4 Mothers 2
22 62 M 5 Male group
23 63 M 5 Male group
24 21 M 5 Male group
25 47 M 5 Male group
26 44 M 5 Male group
F, female; M, male.
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tionships with GPs over a period of time. Many consid-
ered that the GP knew their medical history. By
comparison, relationships with community pharmacists
were more distant and less consistent. It seemed that
although pharmacy staff were considered to be
approachable, there was seldom a sustained relationship
with a particular pharmacist. This resulted in lower levels
of familiarity with pharmacists that did not allow
a rapport to develop undermining interpersonal trust.
The higher quality personal interaction and enhanced
trust in GPs resulted in open and honest discussion, the
cornerstone of effective therapeutic relationships. By
contrast, some participants speciﬁcally discussed being
less likely to discuss sensitive topics with a community
pharmacist.
Other than medicine supply, the most commonly used
community pharmacy services were perceived to be ‘low
risk’. Examples include minor ailment services and
smoking cessation. In particular, young mothers valued
unchargedminor ailment services fortheirchildren.One
participant discussed a positive experience of the phar-
macist’s superior knowledge of over-the-counter medi-
cines, and this established trust in the professional and
the service provided. However, participants frequently
deferred to GPs for ‘serious’ higher risk health concerns.
Those with long-standing health conditions preferred
a GP-led service at all times. There were multiple expla-
nations offered for this. Critically, participants consid-
ered that GPs offer safer services and a more complete
package of care. Speciﬁcally, GPs can diagnose, prescribe,
reference and alter medical records as well as refer to
specialist services if necessary. Most participants who had
long-term conditions considered that medical records
were central to their care. As an example, participants
were concerned that the results of pharmacy health
screening, for example, blood pressure monitoring,
would not result in prescribed treatment or be recorded
in medical records. Some perceived that trusting phar-
macy services could, therefore, seriously threaten their
health. In addition, most considered that the GP would
repeat diagnostic tests carried out at the community
pharmacy, rendering a visit to the pharmacy unnecessary.
Institutional trust
It was clear from data analysis that numerous system/
institutional-based factors could be linked to greater
public trust in GPs relative to pharmacists in the Scottish
setting (see box 3).
Familiarity with traditional roles
Commonly, participants considered that the pharma-
cist’s central role was medicine supply. Even those who
used community pharmacy services extensively, and were
familiar with this route of access, had a limited and
relatively ﬁxed view of the role of the community phar-
macist. Awareness of extended pharmacy services was
low, although knowledge of services did not result in
service uptake. Participants appeared to have established
expectations of health providers and tended to trust
them to deliver familiar services. Participants appeared
reluctant to alter patterns of behaviour.
Personalised service systems
When considering interpersonal trust in health profes-
sionals, the context and setting of interactions is clearly
inﬂuential. In the UK, individuals register with one GP
based in a practice. Therefore, the patient becomes
familiar with one GP, or a limited number of GPs,
allowing a rapport to develop, which leads to trust.
Conversely, people in the UK can choose to use a variety
of community pharmacies for consultations without the
need to register for most services. The ﬂexibility of access
to pharmacy services can result in a lack of allegiance to
any one community pharmacy. In general, GPs are seen
by appointment in a private consultation room, whereas
pharmacists operate no appointment necessary for
consultations in a retail setting. Although participants
expressed frustration with the restrictive GP appointment
systems, and welcomed the relative convenience and ease
of access to community pharmacist consultations, GP
consultations were seen as preferable for clinical discus-
sions. Importantly, the pharmacy setting was not seen to
offer the privacy required for conﬁdential consultations
and health screening. In recent years, community phar-
macies have installed consultation rooms in an attempt to
provide an element of privacy. However, participants were
reluctant to use these due to the consultation room’s
association with the provision of methadone substance
services for problem drug users.
The service setting
Separation of the pharmacist
A number of participants suggested that the GP practice
could be unwelcoming and intimidating and a minority
made positive comments relating to brightly lit open
plan community pharmacies. However, all focus groups
discussed concerns relating to the commercial context
and retail environment of community pharmacy. Inter-
estingly, many commented that pharmacists tended to
be ‘in the back’ and, therefore, out of public view.
Pharmacists derive much of their income from
prescription processing. This activity normally takes
place out of view of the public in the dispensary. The
physical separation of the pharmacist from the ‘serving
area’ in community pharmacy limits public interaction
preventing a rapport developing. Interestingly, some
contended that interacting with the public was not core
to the pharmacist’s role. Some suggested that pharma-
cists should be focused on prescription processing to
minimise the risk of errors.
The commercial context
Participants also perceived that the commercial context
of community pharmacy was at odds with delivering NHS
services; these services are usually free at the point of
access in the UK (see box 1). Our data suggest that
participants question whether pharmacists prioritise
Gidman W, Ward P, McGregor L. BMJ Open 2012;2:e000939. doi:10.1136/bmjopen-2012-000939 5
Public trust in community pharmacy servicesproﬁts or patient care and they distrust pharmacists’
motives. Others seemed confused about how the
commercial aspects of community pharmacy relate to
NHS service provision. Some were concerned about the
increasing dominance of pharmacy chain stores. Despite
concerns about diminishing trust in the NHS, it did
seem that public trust in the NHS as a health service
provider is high relative to commercial enterprise.
38
Hierarchies in healthcare
Importantly, GPs were viewed as established authority
ﬁgures who were seen to ‘tell the pharmacist what to do’.
In fact, some seemed to question whether GPs support
pharmacist interventions. In some cases, participants
looked for tacit signs that GPs supported or endorsed
pharmacy services. One participant speciﬁcally made the
point that, in his experience, the GP is likely to refer
patients to the practice nurse not the pharmacist.
Medical education
There was a common understanding that GPs complete
many years of education at university. Participants
considered that medical qualiﬁcations resulted in GPs
being infallible. Conversely, participants were less certain
about pharmacist education and what it equipped
pharmacists to do. Mistrust in pharmacist education led
many to question the validity of pharmacist’s advice.
DISCUSSION
Overview of ﬁndings
Trust was a central discussion point in all focus groups
and was seen as being crucial in the healthcare setting.
Box 2 Trust, familiarity, conﬁdence and risk
Trust, familiarity and conﬁdence
Importance of familiarity and trust
I think the role of a community pharmacist, you would need to get to know, you know, going back to the same person and getting that rapport
and trust. R1
It’s the trust. R2
Familiarity and safety
. the doctor knows you best. He knows what he can give you safely and what he can’t give you safely. The chemist doesn’t know that. R13
Stability of relationship with GP
Surely a doctor knows your records, he knows your history, he knows you from when you were born till you’re ready to die. A chemist doesn’t. A
chemist can give you something that can have an adverse effect on you. Just as easily as something that would help. R13
Importance of medical history
I would trust the doctor far before I would trust a pharmacist to give me something . because they’ve got your whole history there. R3
Interpersonal trust and communication
If I go to my GP I’m so open about anything I need to say, but with the pharmacist there is that . You don’t feel like there is a personal
relationship that enables you to open up and seek out more advice. R15
Risk
Pharmacist trusted in low-risk situations
Aha . I think they know a lot more than some of the doctors know. I’m thinking about my daughter with the head lice. The doctor didn’t really
know what he could give her. He said, you can try this and you can try that but we had tried that and it didn’t work and she ended up with them
again and again and again eventually the pharmacy was well use this and it worked, it was ﬁne. R18
Pharmacist not trusted in high-risk situations
It’s like they can go and say, ‘Oh it’s nothing’ and then go away and drop dead quick from trusting the chemist. R24
Again it’s what, how much you are expecting the chemist to do for you. R25
I don’t think the chemist would take, I don’t think they would take that type of responsibility. R22
The chemist would take your blood pressure and not prescribe you anything. They’d say ‘Your blood pressure is high so I would see your doctor.
Go to the doctor’. That’s it, end of story. If your cholesterol is that high go to see the doctor. But they can’t prescribe anything anyway. R23
.I would never do, go for anything important like that. I would never use a pharmacist. Just because of the recording of it and it could be sky
high at that time, so what would I do then? I then have to go to the doctor. I would be as well going to the doctor in the ﬁrst place. R3.
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Public trust in community pharmacy servicesFocus groups discussions revealed that participants were
inclined to draw comparisons between GPs and phar-
macists. Our data suggest that public trust in GPs is
greater than that in pharmacists. This contradicts
repeated international surveys, which indicate that the
public rank pharmacists as more trustworthy than
medical doctors.
47e49 It is possible, however, that survey
ﬁndings reﬂect macro-level public trust in the medical
Box 3 Institutional trust
Familiarity with traditional roles
You see the posters about contraception and things like that but because you don’t feel inclined to go ahead and ask the pharmacist, . you
don’t feel that you are comfortable talking to the pharmacist about.. I am more comfortable talking about it with my GP and yet I access the
pharmacy more often than I do the GP, but I’m not comfortable asking the pharmacist about that. Just because of the way.. The service they
give, you just get it in your head, like you just go to pick up medication from there and you are out, you do not have that relationship that you
have with your GP. R15.
Personalised service systems
I wouldn’t say, you know, if somebody said to me ‘where is your community pharmacist?’ I’ll say, well if I go a mile that way I’ll get this one, if I go
a mile that way, and if I go a mile, you know. So it just depends what’s convenient at the time, whereas I think the role of a community
pharmacist, you would need to get to know, you know, going back to the same person and getting that rapport and trust. R4.
The chemist in Renfew has now got a little cubicle and the only people that use that are the ones who’re getting the Methadone. R1.
The service setting
Separation of the pharmacist
What I even ﬁnd at the chemist, the ones coming in. There’s younger people coming in and they’re much more approachable than some of the
older .. You never saw the chemist, he’d stick his head out and that was it, but now they actually come out and ‘How are you doing?’, and stuff
like that. I’ve noticed a big difference in it. R23.
They do really need to get to know you. It needs to be a local thing. To actually get to know you personally. Normally, the pharmacist is not, he
or she is not in what I call the serving area, they’re in the back. You know, and although there are cameras, security cameras, if they’re
concentrating on doing their job, they shouldn’t be looking at the cameras. They shouldn’t actually know who you are. R12.
The commercial context
What I think is bad is the fact that it’s a business, a pharmacist is a business. R3
I think they should be part of the NHS. R3
I don’t like the idea of [pharmacy chainstores] taking over all the individual chemists. R6
Hierarchies in healthcare
. those of us that are older because we’re just not accustomed to going into a pharmacy and saying there’s this wrong with us or that wrong
with us, what can you recommend? We’ve always gone via the GP and the GP decides and tells the pharmacist what to do, you know, about it.
So it takes a bit, I think, when you’re a bit older to slot yourself into that system, so personally I think it comes down to a matter of trust, trust in
what the person’s telling you. R2.
But I’ve never, any times I’ve been to the doctor, I’ve never had him refer me to the chemist. I’ll go up there and he’ll take my blood pressure. If
you go to the doctor to get your blood done, I’m only using that as an example, keeping going on about blood pressure. (Laughs) If you go down
there then he’ll refer you to the practice nurse. R22.
Medical education
Doctors don’t make mistakes. R23
.they’ve had so many years at university to learn this stuff.. R24
So do chemists. R23
Are they going to go to university to learn about all the stuff doctors are and things like this? R24
Do you feel that sometimes some of the advice given in the pharmacist is not .? (facilitator)
It’s not a hundred percent gospel. R24
Or taken seriously because of the difference in the qualiﬁcation thing. R23
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sion. By contrast, study participants were discussing
micro-level interpersonal trust in their own GP and
contrasting that relationship with their personal experi-
ences of community pharmacy. Our data indicate that
familiarity with a speciﬁc GP or practice promoted trust
by allowing a relationship to develop over time. This is
congruent with the theory that trust develops with
familiarity with a speciﬁc individual.
27 34 By contrast,
most people can use any pharmacy they choose to access
services and most did not refer to a strong relationship
with a particular pharmacist.
If we consider our data in the light of Luhmann’s
theories on familiarity, conﬁdence, trust and risk, it is
clear that system/institution factors heavily reinforce
high levels of interpersonal trust in GPs relative to
pharmacists. Familiarity with traditional methods of
service delivery will lead to conﬁdence and trust.
Consequently new routes of service delivery are likely to
be less trusted at the outset. Therefore, it might be
expected that GPs would be the preferred choice for
some services based on familiarity with that route of
access. Additionally, the way in which funding and
patient registration operate in the UK builds trust in
GPs relative to pharmacists. Although GPs and phar-
macists are both NHS contractors, payment systems
differ. GPs typically operate capitation systems and
register patients, whereas in the main community
pharmacy payments do not require registration. The UK
GP registration systems necessitate sustained contact
between patients and speciﬁc GPs. Additionally, NHS
GP services usually involve face-to-face, one-to-one
appointments between GPs and their patients. By
contrast, consultations with community pharmacists are
generally ad hoc, and they occur on the shop ﬂoor in
a retail setting. Patently GP consultations are more likely
to allow trust to develop and are more suited to
discussing personal matters.
Sources of (mis)trust in pharmacy
It is useful at this point to speciﬁcally consider the
sources of (mis)trust in community pharmacy services.
Hall et al
20 proposes that trust comprises ﬁve dimen-
sions. These are ﬁdelity, competence, honesty, conﬁ-
dentiality and global trust. Fidelity relates to putting the
patients’ interests above personal interests. This implies
respect, care and avoiding conﬂicts of interest.
Competence relates to avoiding errors and achieving
optimal outcomes. Patients have difﬁculty in judging
technical competence and assessments of this aspect
relate strongly to practitioners’ communication skills.
Honesty entails telling the truth. Conﬁdentiality
involves protecting sensitive information. Global trust
relates to the less easily categorised holistic aspects of
trust, which cannot be easily described but are linked to
all other aspects of trust.
20 If we apply this framework to
our data, it becomes apparent that there are multidi-
mensional aspects of public mistrust, and possibly
distrust, in pharmacy and pharmacists. The commercial
setting of community pharmacy raised concerns about
ﬁdelity; participants expressed doubts about pharma-
cists’ motives and intentions. Speciﬁcally, the commer-
cial context of community pharmacy created
dissonance as it raised concerns about conﬂicts of
interest. Additionally, participants questioned pharma-
cists’ competence and level of training. Furthermore,
participants were concerned that consultations in the
community pharmacy setting were often conducted in
view of other service users, which raised concerns about
conﬁdentiality.
Dependency on GPs and perceptions of risk
Increasingly, the medical profession occupies a powerful
social position and has growing inﬂuence over resource
allocation in the UK healthcare. The public have no
choice but to trust GPs to access some forms of health-
care due to the lack of alternatives or limited awareness
of alternatives. For example, GPs are gatekeepers for
referral for specialist care. In many situations, the public
are dependent on GPs for medical care whether they
trust the provider or not. Importantly, extended phar-
macy services often duplicate services, which were
historically only available from GPs; consequently,
people are not dependent on community pharmacy for
these services. It was clear from our data that in many
instances participants preferred GP services compared
with pharmacy alternatives.
The patient is dependent on the medical professional
and the medical system in times when ‘expert’ infor-
mation is needed.
50 Importantly, public awareness of,
and conﬁdence in, medical education underpins the
GPs’ expert status. If this is considered in the context of
Luhmann’s theories of power,
29 the GP’s expert
knowledge confers power over the patient. In situations
of risk, the power imbalance between doctors and
patients becomes more deﬁned.
29 As discussed in the
Introduction section, risk is central to understanding
the phenomenon of trust; the greater the risk, the
greater the potential for trust. As public trust in phar-
macists is lower than that in GPs, the public tend to trust
pharmacists primarily in situations that are perceived to
be low risk. Speciﬁcally, they trust pharmacists to deliver
familiar medicine supply services or to conduct ‘low-
risk’ interventions. The public are likely to prefer to visit
GPs for long-term health condition management and
health screening, as these are perceived to be higher
risk and may need specialist referral or access to medical
records.
In the context of previous research
Previously identiﬁed barriers to community pharmacist
role expansion include restricted time for service
delivery, pharmacist workloads, funding, lack of GP
support, lack of public awareness, the community phar-
macy environment and lack of pharmacist knowl-
edge.
16e19 51 Our data concurred with these ﬁndings,
but the application of sociological trust theory and
qualitative approach has helped us unpack this further.
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Public trust in community pharmacy servicesImportantly, identiﬁed barriers can be mapped onto
trust theoretical frameworks. For example, lack of time,
high pharmacist workloads and restricted funding result
in limited patient interaction impeding the formation of
interpersonal trust. GPs head hierarchical structures in
primary care; consequently, lack of support for commu-
nity pharmacy services can erode public trust.
16 17 52 As
outlined, the pharmacy environment also negatively
impacts on public trust.
Policy implications
In recent years, changes in the UK health policy have
promoted an extension to the community pharmacy role
following years of rhetoric claiming that community
pharmacists’ skills are underused.
4 781 05 3 e55 Commu-
nity pharmacist role expansion could potentially reduce
GPs workloads and improve access to health services.
There is mounting evidence that community pharmacy
extended services can be effective.
56 57 Hypothetically,
community pharmacy services could reduce health
inequalities and healthcare costs. However, across the
world, initiatives aiming to extend pharmacists’ roles
have been met with limited success.
11e14 The results of
our analysis suggest that lack of public trust is likely to
explain, at least in part, observed patterns of pharmacy
use among health consumers. It seems that existing
infrastructure, resource allocation and the perceived
level of expertise of pharmacy staff might not adequately
support role expansion.
This study has identiﬁed multiple institutional factors
that underpin enhanced trust in GPs relative to phar-
macists. Policymakers should be aware that, without
considerable changes to systems or institutional aspects
of service delivery, it is improbable that the public will
trust pharmacists to deliver unfamiliar services, which
are perceived to be ‘high risk’. Our analysis helps us to
understand how to develop trustworthy community
pharmacy services in the future. Speciﬁcally, initiatives
that result in well-publicised evidence-based pharmacy
services that coordinate with other primary care services
will facilitate the development of trust. In particular,
funding mechanisms that incentivise conﬁdential
patient consultations over a sustained period with
a speciﬁc pharmacist are likely to build interpersonal
trust. Public trust is likely to improve if community
pharmacy services are endorsed by GPs and integrate
with other primary care services. Currently, it seems that
role expansion gives rise to duplication of tasks because
health professionals’ roles are not complementary.
58
This is likely to increase costs rather than reduce them.
Patently re-engineering pharmacy services to increase
public trust will necessitate new approaches to funding
primary care services to improve public trust. Policy-
makers need to take into account the way in which
public trust is likely to affect patterns of service
uptake.
59
This study indicates that many consider that access to
medical records is necessary for quality healthcare in
many situations. It is not certain whether allowing
pharmacists to access medical records would improve
public trust; clearly, the public has concerns about
conﬁdentiality in this setting. This study also raises
questions about the suitability of overtly combining retail
activities with the provision of NHS services. This
common international model of service delivery may
undermine attempts to extend the clinical role of
pharmacists by diminishing public perceptions of
professional integrity. It is important to note that our
data suggest that the public distrust large commercial
pharmacy chain stores more than the NHS. This is of
broad relevance because there is increasing interna-
tional pressure to allow deregulation of pharmacy
ownership. Indeed, pharmacy deregulation in Europe
has resulted in the expansion of pharmacy chain
stores.
60
Strengths and weaknesses of the study
Previous studies examining community pharmacy
services have considered pharmacist’s and GPs’ opin-
ions
16 19 52; however, few qualitative studies have
considered the general public’s attitudes to extended
services in pharmacies.
18 It is important to consider the
views of the general public, rather than service users,
when considering health promotion and opportunistic
screening interventions, as these services aim to reach
people who may not speciﬁcally be seeking a health
intervention. This is the ﬁrst known paper to explore
trust in community pharmacy by applying sociological
theory. This approach is valuable in that it facilitates
understanding of observed public preferences for routes
of access to primary care services. This study adopted
a qualitative approach and necessarily the sample size is
small relative to quantitative studies. Research of this
type does not aim to be statistically generalisable. Rather
a diverse range of individuals (known users and non-
users) was purposively selected with the aim of exploring
the range of opinions. A further limitation of this study is
that participants were recruited within a speciﬁc
geographical area. The opinions of study participants
might not be representative of those living in other
areas. However, the theoretical informed sample frame
accessed key informants and theme saturation was
achieved.
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APPENDIX 1
Focus group topic guide and questions
What do you understand by the term community pharmacy?
How many of you have been to a community pharmacy recently? What
services did you use and what did you think of the service offered?
What services would you like to see your community pharmacy
provide? (E.G. BP, Cholesterol, CHD Risk assessment, Weight
management, Physical activity advice)
What do you think of these services? Is this the right place for them?
Tell me about any positive or negative experiences you have had in
your community pharmacy?
Are there any other comments or does anyone have anything else to
say about the services provided by community pharmacists?
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